Hongru Li | Brain Metastasis | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Hongru Li | Brain Metastasis | Best Researcher Award

Fuzhou University Affiliated Provincial Hospital | China

Dr. Hongru Li, MD/PhD, is a distinguished clinician-scientist and Chief Physician in the Department of Respiratory and Critical Care Medicine at Fujian Provincial Hospital, Fujian Medical University. With a career dedicated to advancing respiratory medicine and oncology, his expertise lies in lung cancer, metastasis mechanisms, and innovative therapeutic strategies. Over the years, he has combined clinical excellence with groundbreaking research, focusing on molecular pathways and targeted therapies. Dr. Li has published extensively in reputable journals, contributing to understanding brain and bone metastasis in non-small cell lung cancer. His leadership extends to supervising clinical innovation projects funded by national and provincial research grants. Recognized as an outstanding respiratory scholar, he has made notable contributions in translational medicine, bridging laboratory findings with patient care. His research on nanoliposomes, ceramide pathways, and genetic susceptibility in lung cancer exemplifies his commitment to improving treatment outcomes and patient survival in respiratory oncology.

Profile

ORCID

Education

Dr. Hongru Li’s academic foundation is firmly rooted in medicine and specialized respiratory science. He earned his Doctor of Medicine degree at Fujian Medical University, where he developed his core clinical knowledge and interest in pulmonary health. To deepen his expertise, he pursued postgraduate studies in respiratory medicine at Fujian Medical University, gaining hands-on exposure to advanced diagnostic and therapeutic approaches in pulmonary and critical care. His academic journey culminated with a PhD in Respiratory Medicine from Southern Medical University in Guangzhou, where he focused on molecular mechanisms of lung cancer progression and metastasis. His doctoral research provided a solid grounding in translational medicine, integrating clinical insights with cellular and molecular biology. This comprehensive educational background has enabled him to pursue a career balancing patient care with high-impact research, positioning him as a leader in respiratory medicine, oncology, and translational research with a strong focus on innovation and clinical application.

Experience

Dr. Hongru Li has accumulated extensive clinical and academic experience at Fujian Provincial Hospital, where he has advanced through progressive leadership roles in respiratory and critical care medicine. Starting as a resident doctor, he gained experience in managing complex respiratory cases, developing proficiency in critical care interventions. He then served as an attending doctor, where he refined his clinical judgment and mentored junior staff. His expertise led to his appointment as Associate Chief Physician, where he oversaw specialized clinical programs and research initiatives. Currently, as Chief Physician, Dr. Li leads the Department of Respiratory and Critical Care Medicine, managing advanced patient care, research collaborations, and clinical training. His responsibilities span from clinical decision-making to developing research projects funded by provincial and national agencies. With deep involvement in translational research, he bridges laboratory discoveries with real-world patient care, positioning him as both a skilled clinician and an innovative medical researcher.

Awards and Honors

Dr. Hongru Li has been recognized for his exceptional contributions to clinical medicine, research innovation, and academic excellence. Early in his career, he received the Excellent Graduate Award and Excellent Postgraduate Award from Fujian Medical University, reflecting his academic dedication and professional promise. His trajectory of excellence was further reinforced with the prestigious Outstanding Youth Respiratory Scholar Award for Clinical Innovation in China, acknowledging his groundbreaking research and leadership in respiratory medicine. These honors underscore his commitment to advancing lung cancer research, patient care, and translational medicine. His ability to secure competitive research funding and lead innovative studies further reflects his recognition as a trusted expert in his field. In addition, his patents and numerous peer-reviewed publications highlight the impact of his scientific contributions. These accolades collectively demonstrate not only his academic excellence but also his role as a leading physician-researcher shaping the future of respiratory and oncology medicine.

Research Focus

Dr. Hongru Li’s research centers on the molecular mechanisms driving lung cancer progression and metastasis, with particular emphasis on brain and bone metastases in non-small cell lung cancer. He explores signaling pathways, genetic susceptibility, and the role of lipids and ceramide metabolism in tumor development. His studies have investigated proteins such as livin, RPTOR, and ceramide synthase in regulating tumor proliferation, apoptosis, and metastatic spread. Through innovative approaches, including nanoliposome-based therapies, he seeks to inhibit cancer metastasis and improve treatment responses. He has also examined genetic polymorphisms and signaling cascades, such as the PI3K/AKT/mTOR and Wnt pathways, to understand cancer susceptibility and therapy resistance. His translational research aims to transform laboratory findings into clinical applications, offering new diagnostic biomarkers and therapeutic targets. Supported by national and provincial grants, his work significantly contributes to advancing precision medicine, improving survival, and developing novel treatment strategies for patients with lung cancer.

 

Publications

 

Title: KLF9 Inhibits Brain Metastasis of Non‐Small Cell Lung Cancer by Regulating Ceramide Synthase 1 Synthesis
Year: 2025

Title: Efficacy of Prophylactic Cranial Irradiation in Early to Mid-stage Small Cell Lung Cancer Patients in the Era of Magnetic Resonance Imaging
Year: 2024

Title: Development and validation of a nomogram model based on blood-based genomic mutation signature for predicting the risk of brain metastases in non-small cell lung cancer
Year: 2024

Title: Antibacterial effect of phage cocktails and phage-antibiotic synergy against pathogenic Klebsiella pneumoniae
Year: 2024

Title: Clinical application value of metagenome next-generation sequencing in pulmonary diffuse exudative lesions: a retrospective study
Year: 2024

Title: Successful treatment of severe lung cancer caused by third-generation EGFR-TKI resistance due to EGFR genotype conversion with afatinib plus anlotinib
Year: 2024

Title: RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding
Year: 2024

Conclusion

Dr. Hongru Li exemplifies the integration of clinical expertise and research innovation, dedicated to advancing respiratory and cancer medicine through groundbreaking studies, translational discoveries, and compassionate patient care.

Mohammad Ebrahimipour | Microbiology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof Dr. Mohammad Ebrahimipour | Microbiology | Best Researcher Award

 

 

Profile

Education

He holds a PhD in Medical Parasitology from the Department of Parasitology & Mycology at Shiraz University of Medical Sciences, Shiraz, Iran (2017). He earned his MSPH in Medical Parasitology from the School of Public Health & Institute of Public Health Research at Tehran University of Medical Sciences, Tehran, Iran (2012). Additionally, he completed his B.Sc. in Medical Entomology from the School of Public Health at Bandar Abbas University of Medical Sciences, Bandar Abbas, Iran (2008).

 

Work experience

He has presented several research abstracts at prestigious scientific meetings. His work includes a meta-analysis on the prevalence of intestinal parasites among food handlers in Asian and African countries, presented at the 2nd International and 9th National Congress of Parasitology and Parasitic Diseases of Iran (NICOPA9) in Guilan, Iran (May 20–22, 2015). Additionally, he conducted a retrospective analysis of human hydatidosis in Khorasan Province, a hyperendemic area in Iran, which was also presented at NICOPA9.

Further, Dr. [Name] contributed to a study on the rate of Plasmodium vivax infectivity in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency in Hormozgan Province, Iran, showcased at the same congress. Another significant presentation includes research on the prevalence and time-trend analysis of intestinal parasitic infections in Nazarabad, Alborz Province, Iran, based on data from 2012 to 2016, which was presented at the 3rd International and 10th National Congress of Parasitology and Parasitic Diseases of Iran (NICOPA10).

Research interest

He is a member of the Iranian Society of Parasitology since 2017. His research interests focus on the epidemiology of parasitic diseases, particularly vector-borne infections, as well as the clinical aspects and control strategies for parasitic diseases. His work aims to enhance understanding and develop effective interventions for managing parasitic infections in endemic regions.

 

Publication
  • Azizian, M., Oliaee, R.T., Karimazar, M.R., Ebrahimipour, M. and Afgar, A.,
    2023. Time Series Model for Forecasting the Prevalence of Some Important Parasitic
    Infections in Slaughtered Sheep in North-Central Iran. Arch Vet Sci, 27(4)
  • Najjari, M., Rezaeian, S., Sheikhbardsiri, H., Afgar, A. and Ebrahimipour, M.,
    2022. Evaluation of the Prevalence of Malaria and Cutaneous Leishmaniasis in the
    Pre-and Post-Disaster Years in Iran. Prehospital and disaster medicine, 37(4),
    pp.444-450.
  • Najjari, M., Karimazar, M., Ebrahimipour, M. and M Budke, C., 2022. A Review
    of Ethical Issues Related to Laboratory-Based Diagnostics. Medical Laboratory
    Journal, 16(2), pp.1-6.
  • Afgar, A., Vahidi, R., Ebrahimipour, M., Babaei, Z., Mirzaei-Parsa, M.J. and
    Ravari, M.S., 2021. The prediction and expression of miR-203a-p and miR-29b*
    against DNMT3B as well as TNFAIP3 in melanoma. Gene Reports, 25, p.101374.
  • Goudarzi, R., Fasihi Harandi, M., Tasavon Gholamhoseini, M. and Ebrahimipour,
    M., 2021. The Costs of Training Medical Parasitology and Mycology Students at
    Kerman University of Medical Sciences. Strides in Development of Medical
    Education, 18(1), pp.1-6.
  • Ebrahimipour, M., Budke, C.M. and Harandi, M.F., 2020. Control of cystic
    echinococcosis in Iran: where do we stand?. Trends in parasitology, 36(7), pp.578-
    581.

Ibrahim Abbas | Biology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Ibrahim Abbas | Biology | Best Researcher Award 

 

Mansoura University,Egypt

Profile

Education

He is an experienced researcher in Biology, Parasitology, Microbiology, and Molecular Biotechnology, with a strong academic background and extensive research training. He holds a Bachelor of Veterinary Sciences (1999-2004), a Master of Veterinary Medical Sciences (2005-2008), and a Doctor of Veterinary Medical Sciences (Parasitology) (2008-2011) from Mansoura University, Egypt, where his research focused on parasitic infections in farm animals, particularly tissue parasites and Sarcocystis species in buffaloes in Dakahlia Province. To further enhance his expertise, he has undertaken multiple international research experiences, including a one-month externship at TIHO Hannover – Institute of Parasitology, Germany, in 2015, where he worked on PCR-sequencing protocols to genotype hydatid cysts and Taenia hydatigena cysticerci.

He later pursued a six-month postdoctoral scholarship at South Dakota State University (SDSU), USA, focusing on autofluorescence and lectin-binding protocols for identifying gastrointestinal trichostrongylid nematodes in small ruminants under the guidance of Prof. Michael B. Hildreth. His research experience also includes a nine-month postdoctoral scholarship (2018-2019) at the USDA – Animal Parasitic Diseases Laboratory, USA, where he worked on the genetic characterization of Toxoplasma gondii isolates from different regions worldwide, utilizing mice bioassays, cell culture, PCR-RFLP, and whole genome sequencing under the mentorship of Dr. Jitender Dubey. Additionally, he has actively participated in professional training, completing 22 workshops through the Faculties and Leadership Development Program at Mansoura University, along with specialized training in Transmission Electron Microscopy (2010, Alexandria University), Molecular Genetics Approaches (2014, Cairo University), and Micro-imaging for scientific purposes (2016, SDSU, USA). With a diverse research background, advanced technical skills, and extensive international exposure, he seeks opportunities to contribute his expertise in parasitology, microbiology, and molecular biotechnology.

 

WORK EXPERIENCE

 He has had a distinguished academic career in Parasitology, progressing through various academic and research positions. He began as a Demonstrator of Parasitology at Mansoura University, Faculty of Veterinary Medicine, Egypt (2004-2008), before being promoted to Assistant Lecturer (2008-2012) and later to Lecturer (2012-2017). His expertise and contributions to the field led to his appointment as an Associate Professor of Parasitology (2017-2022) at the same institution. Since 2022, he has been serving as a Professor of Parasitology at Mansoura University. In addition to his academic roles, he has undertaken multiple international research assignments as a Visiting Scientist, including at TIHO Hannover – Institute of Parasitology, Germany (2015), South Dakota State University (SDSU), USA (2016), and the USDA – Animal Parasitic Diseases Laboratory, USA (2018-2019). These experiences have significantly enriched his research expertise, particularly in molecular parasitology, diagnostics, and genetic characterization of parasites.

 

Meeting and Workshops

He has actively participated in numerous international scientific conferences and workshops, presenting his research findings in Parasitology. He delivered an oral presentation on the “Genetic diversity and population structure analysis of various Taenia multiceps isolates from definitive and intermediate hosts worldwide” at the British Society of Parasitology (BSP) online meeting held from March 21-25, 2022. He also attended the BSP online meeting in June 2021 and participated in a workshop titled “Virtual Veterinary Vaccines,” organized by Liverpool John Moores University, UK, in collaboration with Chiang Mai University, Thailand, on May 6-7, 2021. In March 2021, he presented a poster on the “Effect of four different preservatives on natural autofluorescence and lectin binding characteristics of trichostrongyle eggs” at the 29th annual online meeting of the German Society for Parasitology. Additionally, he presented a study on the “First report of gastrointestinal parasites of feral cats from Gharbia Governorate, Egypt” at the International Congress on Biological and Health Sciences, Turkey, in February 2021.

He also contributed to the 61st annual conference of the American Association of Veterinary Parasitologists, held in San Antonio, Texas, USA, from August 6-9, 2016, where he presented a poster on the “Simultaneous identification of Haemonchus, Teladorsagia, and Trichostrongylus eggs in goat and sheep fecal samples with three specific lectins.” Furthermore, he attended the 96th annual meeting of the South Dakota Academy of Science in Sioux Falls, South Dakota, USA, on April 8-9, 2016. He has also participated in the 9th International Scientific Conference at the Faculty of Veterinary Medicine, Mansoura University, showcasing his commitment to advancing research in parasitology on both national and international platforms.

Publications

Kamal Ahmad Qureshi | Microbiology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Kamal Ahmad Qureshi | Microbiology | Best Researcher Award

He is a member of prestigious professional organizations, including the American Society for Microbiology (Postdoctoral Membership: 200165352), the American Association for the Advancement of Science (Gold Member: 60484715), and the Saudi Commission for Health Specialists as a Microbiology Specialist (SCFHS: 14-R-A-0030780). His key skills encompass collaboration and teamwork, critical thinking and problem-solving, effective communication of research findings, project management, and continuous learning in microbiology, biotechnology, and drug discovery.

Qassim University, College of Pharmacy, Saudi Arabia

Profile

Education

He holds a PhD in Microbial Biotechnology from Invertis University, Bareilly, Uttar Pradesh, India (2018–2021). Prior to that, he completed an MPhil in Environmental Science with a microbiology-based research project from Savitribai Phule Pune University, Pune, Maharashtra, India (2014–2017). He also earned an MSc in Microbiology (2004–2007) and a BSc in Microbiology (2001–2004) from the same university.

CURRENT EMPLOYMENT

He is currently a full-time Lecturer cum Researcher at the College of Pharmacy, Qassim University, Saudi Arabia, a position he has held since February 2012. As an established researcher, he actively contributes to academic and scientific advancements in his field.

RESEARCH OUTPUT
• Peer-Reviewed Articles – Published
• Peer-Reviewed Articles – Under Revision/Review
• Total Number of Book Chapter – Published
49
03
01
• Total Number of Patent Filed 01
RESEARCH SUPERVISION AND LEADERSHIP EXPERIENCE
• Supervising graduation research projects for PharmD students: 02-03 students/year: Principal
Supervisor
TEACHING MERITS
• Teaching Microbiology, Biotechnology, Immunology, and Molecular Biology to PharmD students.
• Enhancing teaching presentations and facilitating student learning through various learning modalities
and support materials.
• Fostering interdisciplinary collaboration with faculty members from other departments and evaluating
and revising course content to promote student-centered learning.
AWARDS AND HONOURS
• Best Researcher Award-1st Position (2022-2023): Unaizah College of Pharmacy, Qassim University, Saudi
Arabia.
OTHER KEY ACADEMIC MERITS
• Academic Editor: PlosOne and Frontiers.
• Reviewer: Scientific Reports; Foods, Antibiotics, Molecules, Microorganisms, Plants, Biomass, Marine
Drug; Annals of Microbiology; Natural Product Communications; Cogent Medicine, Frontiers in
Microbiology, and Frontiers in Plant Sciences.
SCIENTIFIC AND SOCIETAL IMPACT
• As the leader of a WhatsApp research group comprising around 300 members across various academic
levels in life sciences, I have actively promoted open science and research by facilitating the responsible
distribution of research material and datasets among members. In addition to utilizing our own research
output, we encourage the responsible use of others’ work within our group discussions.
REFEREES
• Dr. Dinesh K. Prajapati, Assistant Professor, Department of Biotechnology, Faculty of Biosciences,
Invertis University, Bareilly, 243123, India, Email: dineshprajapati109@gmail.com, Phone: +91-
9454369931: PhD Supervisor.
• Dr. Pankaj K. Rai, Assistant Professor, Department of Biotechnology, Faculty of Biosciences, Invertis
University, Bareilly, 243123, India, Email: pankajraibhu@gmail.com, Phone: +91-7217011307: PhD
Supervisor.
• Prof. Mariusz Jaremko, Professor, Biological and Environmental Sciences and Engineering Division
(BESE), King Abdullah University of Science and Technology (KAUST), Thuwal, 23955-6900, Saudi
Arabia, Email: mariusz.jaremko@kaust.edu.sa, Phone: +48-696922325: Research Collaborator.

Publications

  • Comparative study of volatile oil constituents, anti-microbial properties, and antibiofilm activities in <i>Eucalyptus camaldulensis</i> and <i>Eucalyptus globulus</i> : insights from central Saudi Arabia

    Journal of Essential Oil Bearing Plants
    2024-03-12 | Journal article
    DOI: 10.1080/0972060x.2024.2324343
    Part of ISSN: 0972-060X
    Part of ISSN: 0976-5026

  • Exploring nature’s hidden treasure: Unraveling the untapped phytochemical and pharmacological potentials of Clinopodium vulgare L. – A hidden gem in the Lamiaceae family

    Heliyon
    2024-01 | Journal article
    DOI: 10.1016/j.heliyon.2024.e24781
    CONTRIBUTORS: Kamal Ahmad Qureshi; Adil Parvez; Mohd Masih Uzzaman Khan; Ashok Aspatwar; Akhtar Atiya; Gamal Osman Elhassan; Riyaz Ahmed Khan; Shakkeela Yusuf Erattil Ahammed; Wasi Uzzaman Khan; Mariusz Jaremko

  • Brucellosis: epidemiology, pathogenesis, diagnosis and treatment–a comprehensive review

    Annals of Medicine
    2023-12-12 | Journal article
    DOI: 10.1080/07853890.2023.2295398
    CONTRIBUTORS: Kamal A. Qureshi; Adil Parvez; Nada A. Fahmy; Bassant H. Abdel Hady; Shweta Kumar; Anusmita Ganguly; Akhtar Atiya; Gamal O. Elhassan; Saeed O. Alfadly; Seppo Parkkila et al.

  • Microalgae: A promising source for biofuel production

    Biocatalysis and Agricultural Biotechnology
    2023-10 | Journal article
    DOI: 10.1016/j.bcab.2023.102877
    CONTRIBUTORS: Sakshi Tomar; Shruti Agarwal; Harshita Singh; Reetesh Kumar; Kamal A. Qureshi; Mariusz Jaremko; Abdul-Hamid Emwas; Pankaj Kumar Rai

  • Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study

    Frontiers in Pharmacology
    2023-08-29 | Journal article
    DOI: 10.3389/fphar.2023.1265573
    Part of ISSN: 1663-9812
    CONTRIBUTORS: Ratul Bhowmik; Ajay Manaithiya; Bharti Vyas; Ranajit Nath; Kamal A. Qureshi; Seppo Parkkila; Ashok Aspatwar